Stifel just flipped to Buy on STAA. The upgrade comes with a $31 target — 49% above Monday's close of $20.87. Short sellers have been heading for the exits at the same time.
Stifel analyst Thomas Stephan raised his rating from Hold to Buy this morning. His new $31 target is up from $28. The timing stands out: Stephan had cut his target to $28 in August following earnings. He is now reversing course decisively.
The broader analyst picture is mixed. Jefferies maintained Buy last week but cut its target to $23 — well below Stifel's new level. Wedbush holds Outperform with a $37 target. UBS sits at Sell with a $19 target. The consensus remains Hold across 11 analysts, with a mean target of $27.70.
The timing of the upgrade coincides with a sharp retreat in short positioning. Short interest has fallen 21.7% over the past week. It now stands at 7.5% of free float — the lowest level in six weeks.
Availability has surged alongside the covering. Shares available to borrow now sit at 441% of current short interest. That means more than four shares are available to borrow for every one already shorted. A month ago availability was at its tightest point of the year. The rapid normalization suggests the covering was orderly, not forced.
Cost to borrow remains negligible at 0.55%. There is no squeeze dynamic here. Short sellers appear to be exiting on conviction, not on pain.
Options positioning tells a slightly different story. The put-call ratio sits at 0.58, against a 20-day average of 0.46. The z-score of 1.40 is elevated but not extreme. Puts have picked up relative to calls since mid-September, suggesting some participants are hedging near-term downside even as the Stifel upgrade lands.
The next earnings date is November 12. Some of the put activity may reflect pre-earnings protection rather than outright bearishness.
Two activists remain on the register with Schedule 13D filings. Neal C. Bradsher holds 32.6% of the company as last disclosed in March. Yunqi Capital holds 6.5% as of January. Both positions are as last disclosed and may have changed. Madison Avenue Partners built an 8.4% stake as recently as August, per a 13G/A filing. The EPS momentum factor ranks at the 78th percentile on a 30-day basis and 82nd on a 90-day basis — suggesting estimate revisions have been running positively ahead of November's print.
What to watch: Whether the Stifel upgrade draws further analyst upgrades ahead of the November 12 earnings date, and whether the put-call ratio normalises back toward its 20-day average.
See the live data behind this article on ORTEX.
Open STAA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
